Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

187

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
M01AB05	REMETHAN	G	Diclofenac sodium - 50mg	50mg	Tablet	196,201 L.L
M05BB03	ACIDE ALENDRONIQUE/ VITAMINE D3 BGR	G	Alendronic acid - 70mg, Colecalciferol - 5600UI		Tablet	815,712 L.L
N03AF01	NEUROTOP RETARD	G	Carbamazepine - 300mg	300mg	Tablet, prolonged release	931,283 L.L
P01AB01	METRIS	G	Metronidazole - 500mg/100ml	0.5%	Injectable solution	142,447 L.L
A10BD20	EMPAZIMET	G	Metformin HCl - 1000mg, Empagliflozin - 5mg		Tablet, film coated	1,840,168 L.L
B01AF01	RIXALTA 20	G	Rivaroxaban - 20mg	20mg	Tablet, film coated	1,164,664 L.L
B05CX01	10% DEXTROSE INJECTION USP	G	Dextrose,H2O - 10g/100ml	10%	Injectable solution	284,997 L.L
C09BA05	TRILTEC PLUS	G	Ramipril - 10mg, Hydrochlorothiazide - 12.5mg		Tablet	2,243,577 L.L
C10AA05	LIPODAR	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	1,323,685 L.L
G03XC01	RALOXIFENE ARROW	G	Raloxifene HCl - 60mg	60mg	Tablet, coated	1,425,817 L.L
J01CA04	AMOXYDIL	G	Amoxicillin (trihydrate) - 250mg/5ml	250mg/5ml	Powder for suspension	142,063 L.L
L01EA01	IMATINIB SPC	G	Imatinib - 400mg	400mg	Tablet, film coated	62,161,280 L.L
P01AB01	METRONIDAZOLE	G	Metronidazole - 500mg/100ml	500mg/100ml	Injectable solution	162,605 L.L
R05DB21	PRIVITUSS	G	L-Cloperastine - 708mg/100ml	708mg/100ml	Suspension	801,186 L.L
A06AD61	SOFLAX	G	Lactose - less than 6g/100ml, Galactose - less than 11g/100ml, Lactulose - 67g/100ml		Solution	258,018 L.L
A10BD20	FLORIMET 5/1000	G	Metformin - 1000mg, Empagliflozin - 5mg		Tablet, film coated	1,836,585 L.L
B01AF01	VAROXA	G	Rivaroxaban - 20mg	20mg	Tablet, film coated	1,343,843 L.L
B05CX01	10% DEXTROSE INJECTION USP	G	Dextrose,H2O - 10g/100ml	10%	Injectable solution	220,643 L.L
C02CA04	CURCARD	G	Doxazosin (mesylate) - 4mg	4mg	Tablet	452,875 L.L
C09BA05	TRILTEC PLUS	G	Ramipril - 5mg, Hydrochlorothiazide - 12.5mg		Tablet	2,189,823 L.L
C10AA05	LIPONORM	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	967,567 L.L
J01CA04	OSPAMOX	G	Amoxicillin (trihydrate) - 250mg/5ml	250mg/5ml	Powder for suspension	223,078 L.L
J01FA09	CLARIDAR DAR AL DAWA	G	Clarithromycin - 125mg/5ml	125mg/5ml	Suspension	295,645 L.L
J05AR01	CONDINE	G	Lamivudine - 150mg, Zidovudine - 300mg		Tablet, film coated	5,818,474 L.L
L01EA01	SAGITTA	G	Imatinib - 400mg	400mg	Capsule, hard	51,723,840 L.L
P01AB01	METRONIDAZOLE B. BRAUN	G	Metronidazole - 500mg/100ml	500mg/100ml	Injectable solution	102,132 L.L
B01AF01	XAVIRAN	G	Rivaroxaban - 20mg	20mg	Tablet, film coated	952,208 L.L
B05CX01	10% DEXTROSE INJECTION USP	G	Dextrose,H2O - 10g/100ml	10%	Injectable solution	252,820 L.L
C02CA04	UNIPROST	G	Doxazosin - 4mg	4mg	Tablet	452,875 L.L
C10AA05	LORVAST	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	1,114,045 L.L

...

187